1. Home
  2. VRME vs ENVB Comparison

VRME vs ENVB Comparison

Compare VRME & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.96

Market Cap

9.2M

Sector

Technology

ML Signal

HOLD

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

N/A

Current Price

$1.49

Market Cap

8.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRME
ENVB
Founded
1999
1994
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
8.1M
IPO Year
2013
2000

Fundamental Metrics

Financial Performance
Metric
VRME
ENVB
Price
$0.96
$1.49
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $1.50
N/A
AVG Volume (30 Days)
★ 5.4M
55.0K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$16,398,000.00
★ $39,914,675.00
Revenue This Year
$36.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.59
$0.57
52 Week High
$1.95
$13.25

Technical Indicators

Market Signals
Indicator
VRME
ENVB
Relative Strength Index (RSI) 57.48 51.26
Support Level $0.67 $1.17
Resistance Level $1.18 $1.53
Average True Range (ATR) 0.17 0.09
MACD 0.04 0.01
Stochastic Oscillator 27.57 44.54

Price Performance

Historical Comparison
VRME
ENVB

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: